For many startup founders and executive boards, the trajectory of a company’s revenue serves as the ultimate scorecard. When top-line metrics climb quarter after quarter, the natural assumption is that the overall health, market standing, and ultimate exit value of the business are moving in lockstep. However, a recent conversation between strategic adviser Itay Sagie and a thriving potential client highlights a critical disconnect that far too many entrepreneurs overlook: a company’s revenue can increase significantly while its total enterprise value quietly moves in the opposite direction.
Sagie, a seasoned lecturer and strategic adviser specializing in growth, strategy, and mergers and acquisitions, recently stepped off the phone with a founder whose company is performing exceptionally well. Yet, the client is entirely dismissive of a potential sale in the near term. The reasoning is rooted in a familiar entrepreneurial ambition: management sees substantial future growth on the horizon over the next couple of years and wants to fully materialize those gains before entertaining an exit, believing that a larger operational footprint will automatically yield a larger payday.
This mindset, while common, overlooks the volatile mechanics of market multiples and valuation compression. Founders and boards routinely track revenue, profitability, and customer acquisition costs with microscopic precision over time. Despite this diligence, another critical graph frequently gets neglected: the trajectory of enterprise value. As Sagie points out, enterprise value can easily turn downward even while a company’s underlying operating numbers continue to improve, a dynamic that carries profound implications for the optimal timing of mergers, acquisitions, and liquidity events.
When Revenue and Value Move in Opposite Directions
To understand how a business can grow larger on paper while shrinking in actual market worth, one must examine the interplay between absolute financial performance and valuation multiples. Founders frequently postpone exit strategies under the assumption that crossing a higher revenue milestone will guarantee a lucrative payout. However, market conditions, shifting investor appetites, and industry maturation can heavily compress the valuation multiples assigned to a business, occasionally erasing the gains achieved through top-line growth.
Consider a hypothetical software-as-a-service company generating $15 million in annual recurring revenue. If the market values that business at a multiple of 6x ARR, its implied enterprise value sits comfortably at $90 million. Fast forward two years: through aggressive sales execution and market expansion, the company successfully increases its ARR by 33% to reach $20 million.
Yet, during that same two-year window, broader market sentiment shifts, interest rates fluctuate, or the sector cools, causing the company’s valuation multiple to compress from 6x down to 3.5x revenue. When applied to the new revenue figure, the company’s enterprise value drops to $70 million. The net result is a stark contradiction: the company’s revenue increased by 33%, but its total enterprise value declined by 22%.
While this scenario uses illustrative assumptions, the underlying economic reality is a constant consideration in corporate finance. It demonstrates how multiple compression can entirely overshadow strong operating growth. For a founder or a board of directors choosing to delay an acquisition process in pursuit of a specific revenue target, the practical takeaway is sobering: reaching that milestone does not necessarily prevent a smaller exit. If the multiple contracts faster than the top line expands, the shareholders may ultimately receive less value for a larger business.
Qualitative, Absolute, and Relative Factors
The revenue multiplier assigned to any given company is rarely arbitrary; rather, it reflects a complex synthesis of several distinct dimensions that rarely evolve at the same pace. Understanding these underlying drivers requires looking beyond simple financial statements to examine qualitative, absolute, and relative performance indicators.
Qualitative factors form a major pillar of how strategic buyers and private equity firms price an acquisition target. These intangible elements include the overall quality and depth of the management team, the degree of founder dependence, the intensity of current and prospective competitive pressures, the distinctiveness of the company’s product differentiation, and its direct strategic relevance to potential buyers. A company that relies too heavily on its founder, for instance, may see its valuation multiple suffer even as revenues climb, because buyers perceive higher key-person risk.
At the same time, absolute financial measures provide the bedrock of valuation. These include raw top-line revenue, earnings before interest, taxes, depreciation, and amortization, and free cash flow generation. Buyers evaluate these metrics to understand the sheer scale and financial stability of the target business.
Alongside absolute figures sit relative performance measures, which track growth trajectories, operating margins, net revenue retention, and gross revenue retention. Although retention metrics are typically expressed as percentages, their true importance lies in what they communicate about customer durability, product stickiness, and the potential for organic account expansion. Prospective buyers assess all of these measures collectively, benchmarking the target company against relevant industry peers.
As companies mature and scale, a natural tension often emerges: their absolute financial results continue to improve, but their year-over-year growth rates inevitably begin to decelerate. Meanwhile, stronger profitability, improved customer retention, or the development of a deeper, more independent management layer may help support or even elevate a company’s multiplier.
Ultimately, the final valuation outcome depends on the combined net effect of these competing forces. Because these dynamics shift constantly, corporate boards should actively interrogate their strategic assumptions. They need to ask which specific company characteristics are likely to improve over the coming year, which could realistically deteriorate, and how sophisticated buyers might price those changes into an offer.
M&A Preparation Should Begin While You Are Winning
Executing a successful company sale is rarely a quick transaction; it requires rigorous preparation, active buyer engagement, intense negotiation, and exhaustive due diligence. Throughout this prolonged process, prospective buyers continually reassess the company’s historical performance, current execution, and future forecasts.
Waiting to explore a sale until an operational slowdown or a market plateau becomes visible can severely weaken a board’s negotiating leverage. It can also raise difficult questions among buyers regarding management’s long-term projections and the underlying health of the business.
Furthermore, strategic buyer demand operates on its own independent timetable. A major competitor or strategic acquirer may place a remarkably high value on acquiring a specific proprietary technology, an established customer base, or a particular geographic footprint today. However, that intense interest can diminish rapidly following an internal product launch, a competing acquisition in the same space, or a sudden shift in corporate budgetary priorities.
This is not to suggest that delaying an exit is always a mistake. Waiting can still create considerable shareholder value under the right circumstances—particularly when achieving additional operational scale attracts a broader pool of prospective buyers, when profitability reaches an inflection point, or when customer and revenue concentration decreases.
Corporate boards can make these strategic trade-offs tangible by regularly reviewing estimated enterprise value alongside the company’s core operating plan. This involves running scenario analyses that model out what happens to shareholder proceeds if revenue grows while the valuation multiple holds steady, expands, or contracts. Boards should also factor in how debt, cash reserves, equity dilution, liquidation preferences, and specific transaction terms will ultimately affect the cash distributed to shareholders.
Because nobody can reliably identify the exact valuation peak of a company or a market cycle in advance, every conscious decision to delay a sale embeds a distinct viewpoint about future valuation. As founders and directors weigh their options for the future, that underlying bet deserves as much scrutiny and tracking as the revenue graph itself.
